The development of accurate, safe, and efficient gene delivery remains a major challenge towards the realization of gene therapeutic prevention and treatment of cardiovascular diseases. In this study, we investigated the ability of high-intensity focused ultrasound (HIFU), a form of mechanical wave transmission, to act as a noninvasive tool for the enhancement of in vivo gene transfer into rabbit carotid arteries. Segments of the common carotid arteries of New Zealand white rabbits were isolated and infused with plasmid DNA encoding the reporter b-galactosidase either with or without the addition of ultrasound contrast agent consisting of small (B2-5 mm) gasfilled human albumin microspheres to augment cavitation. Infused arteries were exposed to pulsed ultrasound for 1 min (frequency 0.85 MHz, burst length 50 ms, repetition frequency 1 Hz, duration 60 s, peak pressure amplitude of 15 MPa). At 6.3 MPa, HIFU enhanced gene expression eight-fold, and 17.5-fold in the presence of contrast. We found increasing amounts of b-galactosidase expression in the carotid vessel with increasing pressure amplitude. This dose-response relation was present with and without contrast. Without contrast, no vessel damage was detected up to 15 MPa, while the addition of contrast induced side effects above a threshold of 6.3 MPa peak pressure. The entire procedure was feasible and safe for the animals, and the results suggest that HIFU has the potential to assist in the noninvasive spatial regulation of gene transfer into the vascular system.
Introduction
Gene therapy has emerged as a promising approach for the treatment of cardiovascular diseases. [1] [2] [3] [4] However, the efficient and safe delivery of therapeutic genes in vivo remains a major challenge towards the realization of gene-based therapeutic strategies.
Increasing evidence shows that exposure of eucaryotic cells to modest intensity ultrasound, either alone or in combination with other nonviral techniques, can enhance transgene expression by up to several orders of magnitude over naked DNA alone. 5, 6 Adenoviral vectors have achieved relative efficiency in the vessel wall, but only in the setting of acute endothelial damage and at the cost of inflammatory and immune reactions that limit their effectiveness. Other viral vectors, such as adeno-associated virus, have been less successful in their application to the vasculature, and all viral vectors pose potential safety hazards of viral mutations and cytologic complications. On the other hand, nonviral vectors for gene delivery that carry less risk generally yield less efficient transfection. 3, 5 While it is known that simple exposure of cultured cells to naked DNA can result in DNA uptake, therapeutically relevant transfection efficiencies in vivo are difficult to achieve. As a result, a variety of methods to increase the effectiveness of nonviral vectors have been investigated, such as electroporation, application of DNA to accelerated gold particles, and exposure to controlled pressure. [6] [7] [8] [9] Although these methods have been demonstrated to enhance transfection efficiencies in a variety of tissues and cell types, widespread clinical application of many gene transfer strategies await further improvements on gene transfer methodology. In addition, many therapeutic strategies would benefit from a noninvasive means of directing gene transfer to a specific tissue site.
It is a well-accepted concept that structural and mechanical properties of tissues and cells may influence the process of DNA transfection and/or gene expression. Mechanical disruption of the endothelium has been reported to enhance viral gene delivery into vascular smooth muscle cells of the vessel wall, 10 and the uptake of plasmid or oligonucleotide DNA in cardiovascular tissues has been shown to be enhanced by delivery in a pressurized environment.
Depending on the physical parameters, ultrasound as a mechanical wave transmission is in broad clinical use for both diagnostic and therapeutic medical purposes. for example, ultrasonic shockwaves are used for the nonthermal destruction of kidney stones in lithotripsy, and high-intensity focused ultrasound (HIFU) is clinically used for the thermal ablation of tumors. It has been suggested that ultrasound waves may therefore also be able to alter cellular tissue properties in a controlled manner within a well-defined anatomical region to enhance gene transfer. Accordingly, ultrasonic shockwaves 11 and low-dose sinusoidal ultrasound have been shown to permeabilize cell membranes and mediate the transfer of proteins, 12 and molecules such as dextranes into cells. 13 It has also been demonstrated that ultrasound enhances the transfer of plasmid DNA into cells in culture, [14] [15] [16] [17] [18] [19] skeletal muscle in vivo, 20, 21 and experimental tumors in vivo. 22 A wide range of ultrasonic waves have been used to augment gene transfer such as low-level diagnostic ultrasound, 20 ultrasonic shockwaves 22 and HIFU. 23 Furthermore, the application of ultrasound towards cardiovascular gene therapy was suggested in recent reports that demonstrated enhanced reporter gene expression following unfocused low-dose ultrasoundassisted transfection of vascular smooth muscle cells and cardiac myocytes 24, 25 in the vessel system in vivo.
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In the present study, we hypothesized that the use of focused sinusoidal ultrasound at higher intensities (HIFU) during intralumenal DNA administration could enhance the expression of reporter plasmid DNA in rabbit carotid artery in vivo. We used HIFU because these waves can in principle be directed from the outside to a defined anatomical region, while intermediate layers can be spared, which has been demonstrated by magneticresonance-imaging-guided HIFU-induced thermal tumor ablation. 27 Here, we applied focused ultrasound bursts repeated at the rate of one per second that induced a small-amplitude movement of the artery visible through the transparent cone which allowed alignment corrections ( Figure 1 ). We also investigated the dose dependency of transgene expression and adverse effects on the HIFU pressure level. Furthermore, transgene expression and adverse effects were investigated in dependence on cavitation using ultrasound contrast agent microbubbles consisting of small (B2-5 mm) gasfilled human albumin microspheres. 28 
Results
The application of focused ultrasound (HIFU) to isolated segments of rabbit carotid artery that were filled with DNA solution yielded a substantially increased degree of reporter gene expression measured via ELISA of vessel protein extracts 48 h after HIFU treatment (Figure 2 ). An eight-fold increase at 6.3 MPa was measured (9927690 pg/mg protein versus 125727 pg/mg in nonsonicated vessel exposed to DNA solution, P¼0.025). Most of the sonications were performed at this power level since it was the maximum that did not produce vessel damage with the contrast agent (see below). The addition of contrast bubbles to augment cavitation during HIFU exposure has been found to enhance transgene expression in cells in vitro. We therefore measured b-galactosidase protein 48 h after the sonication of segments of rabbit carotid containing 200 ml of b-gal plasmid DNA solution (200 mg) and 50 million bubbles/ml for 1 min at a pressure amplitude of 6.3 MPa.
Transgene expression approximately doubled compared to sonication of vessels filled with DNA solution alone (21807744 pg/mg protein, P¼0.02), which represented a 17.5-fold increase in transgene protein expression com- Figure 1 Schematic diagram of the sonication setup. The focused ultrasound (0.85 MHz) propagates from the transducer through the cone filled with water directly to the vessel to ensure optimal coupling and targeting. The sonication pulse is given for a total exposure time of 1 min at a pulse rate of 1 Hz with a burst length of 50 ms, allowing one to detect a small vessel amplitude which facilitates correct targeting of the vessel. The surgically exposed common carotid artery which was canulated via an external branch, flushed with transfection medium, and sonicated at three sites along the vessel at a distance of approximately 1 cm. One additional sample per artery was infused with DNA, but was not sonicated. Contralateral arteries served as controls. HIFU induces reporter gene expression in rabbit carotid arteries PE Huber et al pared to control arterial segments filled with the DNA solution that did not receive HIFU treatment (Po0.001, Figure 2 ). The addition of bubbles to the DNA transfection solution compared to control DNA solution did not increase transgene protein expression (170765 pg/mg, P¼0.9, Figure 2 ).
The dose-response relation of transgene expression was investigated via b-gal protein measurements after the application of various ultrasound pressures up to 15 MPa (acoustic power of 155 W). Figure 3 demonstrates that although a significant degree of biological variability typical of all known in vivo gene transfer methods was observed, the amount of b-galactosidase protein did increase with increasing ultrasound pressure (linear regression coefficient r¼0.622, Po0.0001). This dosedependent effect was seen both in the samples treated with contrast bubbles and in those exposed to DNA alone (r¼0.81, Po0.0001).
In all treatment groups collectively, a minimal level of transgene expression was observed after infusion of isolated arterial segments with DNA solution in the absence of HIFU application (1807156 pg/mg protein versus 27.5722 pg/mg in contralateral carotids that were not perfused with DNA, P¼0.02), and this level of expression was not influenced by the addition of contrast bubbles to the DNA (1947173 pg/mg protein, P40.5 versus DNA without bubbles). Comparison of b-galactosidase protein expression in the proximal, medial, and distal areas of sonication treatment on the carotids in all treatment groups revealed no significant difference between sonication sites (Figure 4 , P40.5). The analysis of the sections for X-gal staining in four animals treated with ultrasound in the presence of DNA with or without contrast agent revealed no unambiguously stained positive cells, although the staining procedure was repeated twice, presumably due to the low sensitivity of the X-gal staining method.
The focused ultrasound treatment procedure itself was found to be safe for the animals and feasible in all cases. No signs of acute systemic adverse reaction were observed either during the therapy or the following 48 h period. At harvest, the vessels showed no visible signs of adverse effects or thrombosis following the ultrasound transfection procedure. Immediately after sonication in the presence of bubble contrast medium, however, changes such as whitening of the vessel wall and small punctate hemorrhage of the adventitial vasa vasorum were observed, and the incidence of these visible vessel wall changes increased with increasing ultrasound pressure ( Figure 5 ). The punctate hemorrhages became more apparent after reperfusion of the carotid. Both whitening and hemorrhage were limited to the 2 mm diameter area of HIFU application. The sonication of the vessels with DNA in physiologic saline solution (0.9% NaCl) did not result in any visible vessel wall changes up to a pressure amplitude of 15 MPa. In contrast, the addition of contrast agent bubbles induced whitening of the artery wall above 6.3 MPa peak pressure amplitude of the sinusoidal soundwave. At 8.2 MPa approximately 54% of the sonicated vessels exhibited hemorrhages at the vessel surface, and above 10 MPa all vessels exhibited hemorrhage without apparent disturbance of the blood flow. At pressures above 10 MPa, frank puncture of the arterial wall was observed in some cases, although control of bleeding and vessel patency was achieved in each instance. In no instance did any of the HIFU-treated vessels differ in their macroscopic appearance from control vessels at the time of harvest 48 h after HIFU treatment.
Correspondingly, in the 10 animals used for H&E histology, we found no differences in carotids of animals killed 2 days after sonication, compared to controls. No inflammatory or immune reactions up to ultrasound (Figure 6a ). This lack of acute adverse effects transformed also to a lack of neointima formation in animals killed 2 weeks after treatment (Figure 6b ).
Discussion
The data presented here demonstrate the ability of focused ultrasound to enhance in vivo plasmid DNA reporter gene expression in the rabbit carotid artery. Recent in vitro studies have found that adjunctive sonication with low-dose ultrasound enhances reporter gene expression in vascular smooth muscle cells (VSMCs). 24 In vivo, ultrasonic shockwaves 18 and focused sinusoidal ultrasound, 23 similar to the ultrasound used in the present studies, have been reported to mediate transfection in experimental tumors and enhance reporter gene expression in vivo after direct intratumoral DNA plasmid injection. Other, lower levels of ultrasound have been used to transfect the vessel system. 26 Echocardiographic destruction of albumin microbubbles have also been reported to direct gene delivery to the myocardium. 25 Moreover, after systemic administration, ultrasound has been reported to enhance cationic lipidmediated gene transfer to primary tumors. 28 A variety of ultrasound sources with respect to focusing, waveform, and intensity level have been applied to augment transgene expression. Focused sinusoidal ultrasound, as studied in the present work, may achieve the best proportion of transfection and cell viability, 19 since the effects of this type of ultrasound can be focused on a defined target area, while sparing the surrounding tissue. At a pressure amplitude of 6.3 MPa, an approximately eight-fold increase in b-galactosidase protein expression was seen in the present studies after HIFU treatment of rat carotids in vivo in the presence of intralumenal plasmid DNA. Cavitation augmentation using a solution containing ultrasound contrast bubbles enhanced transgene expression to 17.5-fold. In general, increasing ultrasound intensities were associated with increased amounts of b-galactosidase protein, suggesting an ultrasound dose response. The addition of ultrasound contrast agent bubbles further increased reporter gene expression for each pressure point, which strengthens the importance of cavitation in this interaction. Since the ultrasound focus is relatively small compared to the resected tissue specimen analyzed in the ELISA for transgene expression, the fold stimulation locally achieved might even be higher than the reported numbers. Thus, to induce a more homogenous transfection in a given tissue area, the ultrasonic focal region could be broadened, or the focus should be moved to cover the entire target area to be transfected. On the other side, the exactly targeted transfection might also be of interest under certain clinical circumstances.
Our data also confirm the important role of cavitation as a nonthermal bubble phenomenon in the effects of ultrasound-enhanced gene expression, as suggested by other groups in recent reports. [29] [30] [31] [32] The sonication procedure was feasible in the present study, and the animals tolerated the 1 min sonication with focused ultrasound well. Visible mild adverse effects such as punctate hemorrhage were dose dependent and occurred above a threshold pressure of 6.3 MPa, while severe adverse effects such as puncturing of the artery were observed above 10 MPa pressure amplitude in the presence of cavitation contrast agent bubbles. No adverse effects were seen if carotids were sonicated in physiologic saline solution only up to 15 MPa peak pressure. In the future, threshold values for these local side effects could be determined for different species, vessel wall thicknesses, and other ultrasound parameters. Although the ELISA test demonstrated increased gene expression after ultrasound, in the b-galactosidase staining, we could not detect b-gal-positive cells, presumably because of the low sensitivity of the X-gal staining procedure or a low protein expression per cell, which has been documented in earlier ultrasound studies. 23 Therefore, we were not able to assess transmural distribution of transgene expression. This discrepancy is a potential weakness of the study. Further studies are needed to specify cell types and show the geographical location and the layers of the vessel wall that are targeted by this in vivo gene transfer approach.
In principle, focused ultrasound may also be used as a tool to noninvasively direct energy to a defined area in the human body with great variety of physical dose deposition. 27, [33] [34] [35] Although tested in this study via an open surgical approach, ultrasound can be focused in a range of 1-50 mm 3 that can be positioned at variable depth when applied across the intact skin. Although ultrasound restrictions do occur at bone structures and air interfaces such as the lungs where ultrasound waves are partially reflected, all locations in the human body can be accessed either by noninvasive transcutaneous or minimally invasive endoluminal ultrasound devices. If the target volume exceeds the ultrasound focus, multiple exposures can be made. An important advantage of focused sinusoidal ultrasound as a gene transfer tool may involve the potential combination with radiological noninvasive monitoring devices such as magnetic resonance imaging (MRI), diagnostic ultrasound, or other HIFU induces reporter gene expression in rabbit carotid arteries PE Huber et al imaging modalities to noninvasively direct highly localized gene transfer to a well-defined tissue target. 36 This radiological method could finally allow a noninvasive targeting and monitoring of sonication-mediated gene delivery through the intact skin.
Although the intralumenal DNA infusion sets a spatial limitation of gene expression to the vessel system even for unfocused sonications from the outside, in humans in vivo it can be difficult to always restrict gene transfer to the planned sites. Moreover, since we found a doseresponse relation between ultrasound dose and gene expression, it is conceivable that unfocused ultrasound cannot reach the same level of gene expression in equivalent systems because of potential ultrasoundrelated side effects in adjacent organs at risk, for example bones. In contrast, ultrasonic focusing has the advantage of spatial control and minimizing potential unwanted effects in adjacent tissue.
Although the mechanism of enhanced gene expression after ultrasound as a pressure wave is not yet fully understood, high static pressure 11, 13 and ultrasoundinduced prolonged interaction of cell membranes with the DNA present at the surface 37 are potentially involved.
Ultrasonically induced heat elevation has not been reported to be an important mechanism of transfection induction, 23 while acoustic cavitation as a nonthermal phenomenon is considered to augment ultrasoundmediated transfection. 26, [29] [30] [31] [32] Cavitation involves the formation of gaseous bubbles, a few micrometers in diameter, because of a disruption of the propagation medium by the negative pressure cycle in ultrasonic fields. 38 These cavitation bubbles can oscillate in response to ultrasound fields, possibly influencing the surrounding structures such as membranes. Alternatively, they can have effects on the tissue including tumor Figure 6 Histology of rat carotids (H&E, top 2 Â , bottom 20 Â ). Isolated carotid artery was infused with plasmid DNA encoding b-galactosidase and physiologic saline or additionally infused with ultrasound contrast agent bubbles and treated with focused ultrasound (6.3 MPa peak pressure, 1 min sonication burst frequency 1 Hz with a burst length of 50 ms). Control: no sonication; ultrasound: focused ultrasound; ultrasound+bubbles: focused ultrasound in the presence of contrast agent bubbles. (a) 2 days after ultrasound; (b) 2 weeks after ultrasound.
HIFU induces reporter gene expression in rabbit carotid arteries PE Huber et al cytotoxicity 34 when they implode, resulting in high local pressures, shear forces, and in highly localized temperature increases of more than 5000 K without significant macroscopic tissue temperature elevation. 39 Supporting this hypothesis, the addition of ultrasound contrast agent acting as artificial cavitation bubbles further increased transfection efficiency in the present in vivo study.
The optimal ultrasound parameters for transfection such as sonication time, pressure, frequency, averaged intensity, and cavitation dose have not been systematically characterized. 5, 6, 14, 16, 17, 19, 20, 32 Sinusoidal focused ultrasound transfection can be applied at an intensity level without substantial side effects, and, unlike a number of viral gene transfer vectors, multiple, repeated ultrasound transfection applications are possible. Further improvements of efficiency are therefore possible, including the use of adjuncts such as liposomal sheltering of plasmids. 41 Although effective gene therapy in cancer using ultrasound augmentation has recently been described, 42 potential adverse effects such as capillary rupture by cavitation must be taken into account. 43 The potential advantage of focused ultrasound over other ultrasound methods, as a physical transfection tool, may therefore be the precise and local delivery of ultrasound energy deep in tissue, while sparing the surrounding tissue thus minimizing potential hazards.
In summary, our results indicate that focused ultrasound is a promising method to achieve enhanced gene expression in an arterial vessel wall in vivo after intravascular plasmid DNA administration. In combination with the flexibility and excellent clinical safety profile of therapeutic and diagnostic ultrasound, the data suggest that ultrasound-assisted gene delivery can improve the efficiency of nonviral gene delivery.
Methods

HIFU generation
Sonication with focused ultrasound was performed with a cone-like custom-made device that could be flexibly positioned and directly targeted to a specific arterial segment under direct surgical exposure (Figure 1 ). The ultrasound fields were generated with a spherically curved air-backed piezoelectric transducer with a 100 mm diameter, an 80 mm radius of curvature, and a resonant frequency of 0.85 MHz (constructed by the investigators; the transducer element was custom made by Channel Industries Inc., Santa Barbara, CA, USA), resulting in a focal width of approximately 2 mm and focal length of 8 mm. The acoustic pressure was measured in water using a hydrophone (Sonic Industries, Hatboro, PA, USA). The pressure amplitude was varied between 0 and 15 MPa, corresponding to a maximum acoustic power of 155 W. The sonication time was 1 min, the pulse repetition frequency was 1 Hz with a burst length of 50 ms with 42500 cycles resulting in a duty cycle of 5%. The ultrasound bursts repeated at the rate of one per second induced a small amplitude movement of the tissue in the ultrasound focus that was visible through the transparent cone, allowing for alignment corrections if necessary. Therefore, the sonication spot could be monitored by eyesight and controlled during the entire 1 min sonication with good spatial accuracy. In general, after the first five pulses, that is 5 s, the correct and final position was found and kept through the entire 1 min sonication. The RF power (both forward and reflected) was measured just before and after the sonications, thus assuring the exposure levels.
Animal model and transfection condition
The experiments were all approved by the institutional animal committee. A total of 27 3-4 kg New Zealand white rabbits were used, 11 animals were assigned to the group HIFU and contrast agent, six animals were assigned to the group HIFU alone. General anesthesia was induced in the rabbits via intravenous injection of xylazine (5 mg/kg) and ketamine (35 mg/kg) through an indwelling 24-gauge catheter placed in the marginal ear vein. The procedure was undertaken under strict sterile technique. A vertical midline neck incision was made to expose the common carotid artery and its bifurcation. The animal was then systemically heparinized (100 U/kg i.v.). The common carotid was clamped proximally, and the internal carotid was clamped distal to the bifurcation using atraumatic clamps. An infusion catheter was then advanced into the common carotid artery via canulation of the external branch, and the vessel flushed with normal saline solution. The transfection medium (200 ml) consisting of 200 mg plasmid DNA encoding the reporter b-galactosidase suspended in a physiologic solution (0.9% NaCl), was then infused into the isolated segment. The reporter construct was a derivative of RC/CMV (Invitrogen Corporation) that expresses the reporter gene b-galactosidase (CMV-LacZ) under the control of the cytomegalovirus promotor.
Three defined positions of the isolated segment of the carotid artery at a distance of approximately 1 cm were exposed to focused ultrasound applied across the adventitial surface of the vessel (Figure 1 ). To ensure that the sonicated areas could be accurately identified at the time of harvest, the sites were marked via placement of a 7-0 prolene suture tag in the adventitia directly proximal to the treatment site. Prior the sonications, sterile acoustic gel was placed on and around the carotid artery to provide good coupling for the ultrasound. After sonication was complete, the vessel segment was flushed prior to unclamping, the cannula was removed, and the external branch was ligated. Blood flow was then restored through the common carotid and internal carotid by removal of the clamps.
In an effort to investigate the role of cavitation in ultrasound-mediated transfection, plasmid DNA transfection media was mixed with an ultrasound contrast agent (Albumex (Mallinckrodt Medical, St Louis, MO, USA) consisting of small (B2-5 mm) gas-filled human albumin microspheres resulting in a final concentration of 5 Â 10 7 bubbles/ml of transfection media. These gaseous contrast bubbles had been shown to enhance ultrasound-mediated transfection in vitro via increased cavitation. [28] [29] [30] [31] [32] Both the treated carotid arteries and the contralateral carotids were harvested 48 h after sonication. Up to three vessel segments, 0.5 cm in length, containing areas of sonication, along with the segment that contained DNA infusion only, were immediately frozen in liquid nitrogen. Up to two segments from the contralateral artery, which were not perfused with plasmid DNA solution, were harvested and frozen as controls. Additionally, aortic segments from animals never exposed to plasmid DNA were harvested and frozen as controls.
In these tissue samples, b-galactosidase protein concentration was quantified using an ELISA (3 Prime-5 Prime, Boulder, CO, USA) according to the instructions of the manufacturer. The tissues were ground to powder and cell lysates were prepared using lysis buffer (10 mM Tris-Cl, pH 8, 1 mM PMFS, 1 mg/ml Aprotinin). Tissue debris was pelleted by centrifugation at 14 000 g and total protein concentration was determined using the Bradford assay (Biorad Laboratories, Richmond, CA, USA). Absorbance values were quantitated using an ELISA plate reader at a wavelength of 405 nm. bGalactosidase protein quantity was determined as picogram b-galactosidase per milligram total protein. All tissue samples were measured in triplicates in the ELISA reader and average values were assigned to the samples. N¼34 samples could be analyzed in the group HIFU with contrast bubbles, and 20 samples in the group HIFU without contrast.
Histology
To assess for potential adverse effects of the ultrasound transfection method on the vessel wall, a total of 20 carotids in another 10 animals were resected either 48 h or 14 days, respectively, after treatment, fixed in buffered formalin and embedded in paraffin. Sections were stained for H&E or with X-gal buffer (1 mg/ml 5-bromo-4-chloro-3-indoxyl bgalactoside, 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 2 mM MgCl 2 ] for b-galactosidase-positive cells, as described.
Statistical analysis
For multiple comparisons, ANOVA was used with Fisher's least-significant difference (LSD) method. For dose-dependence analysis, a linear regression was calculated assuming a linear dependence in the first approach. All analyses were performed with the Statistica 5.0 software program, and all tests were two-tailed. A P-value of 0.05 was considered as significant.
